Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31
Phase 42

Trial Status

Completed8

Role Distribution

Other Roles8

Activity Timeline

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (8)

Showing 8 of 8 trials

NCT03750188StudyDirector

Evaluation of Safety and Efficacy of ProHance in Pediatric Patients <2yrs

Central Nervous System DiseasesCentral Nervous System Neoplasms
Completed
NCT00408083Phase 3StudyDirector

Crossover Study With MultiHance vs a Comparator for Peripheral MRA

Peripheral Vascular Disease
Completed
NCT00600834StudyDirector

Evaluation of the Risk of NSF Following ProHance Injection in Patients With Chronic Kidney Disease

Renal Insufficiency
Completed
NCT00600951StudyDirector

Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney Disease

Renal Insufficiency
Completed
NCT00773409StudyDirector

Evaluation of the Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Without Exposure to Gadolinium Based Contrast Agents (GBCA)

Renal Insufficiency
Completed
NCT01613417Phase 4StudyDirector

Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain

Brain Disease
Completed
NCT02070380Phase 4StudyDirector

Crossover Comparison of MultiHance and Dotarem

Brain Disease
Completed
NCT03108378StudyDirector

Evaluation of Gd Retention in Human Bone and Skin After MultiHance or ProHance Administration Compared With Control

Gadolinium Retention
Completed

All 8 trials loaded